10 suspended. 10 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Suspended 10 |
| Phase 1 | 2 | Suspended 2 |
| Phase 3 | 1 | Suspended 1 |
Follow Head and Neck Neoplasms: new trials by email Literature Review of Head and Neck Neoplasms trials Research Report on Head and Neck Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEARTS Trial for Thoracic Cancers MRgART, LINAC - Non-Small Cell Lung Cancer (Stage III), Esophageal Cancer Stage I-III | Phase 2 | Suspended | University of Wisconsin, Madison | 60 | 2025-10-08 | 2026-10-30 |
| Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma | Phase 2 | Suspended | National Cancer Institute (NCI) | 50 | 2024-02-19 | 2026-11-02 |
| Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in 77 Lu-DOTA0-Tyr3-Octreotate - Metastatic Nasopharyngeal Cancer | Phase 2 | Suspended | National Cancer Centre, Singapore | 25 | 2023-05-05 | 2026-05-22 |
| A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 ChAdOx1-MAGEA3-NYESO (Route = IM injection, Dose = 5×10^10 vp), MVA-MAGEA3 (Route = IM injection, Dose = 1.3×10^8 pfu), Standard of care treatment - Non-small Cell Lung Cancer (NSCLC), Squamous Oesophageal Cancer | Phase 1 / Phase 2 | Suspended | Cancer Research UK | 15 | 2021-10-15 | 2026-04-06 |
| A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Toripalimab injection (JS001), Paclitaxel, Albumin-Bound, Radiotherapy - Esophageal Squamous Cell Carcinoma | Phase 2 | Suspended | Zhejiang Cancer Hospital | 100 | 2019-09-07 | 2021-02-23 |
| Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer (18)F-Fluoroazomycin arabinoside, Pimonidazole - Tongue Cancer | Phase 1 / Phase 2 | Suspended | Sunnybrook Health Sciences Centre | 10 | 2018-01-25 | 2024-08-12 |
| UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone Lenvatinib, Everolimus - Thyroid Cancer | Phase 2 | Suspended | Thomas Jefferson University | 5 | 2017-04-03 | 2021-10-15 |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Atorvastatin, Placebo - Nasopharyngeal Carcinoma, Radiation Therapy Complication | Phase 2 | Suspended | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 324 | 2017-01-01 | 2017-12-04 |
| Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Atezolizumab, Biopsy Procedure, Biospecimen Collection - Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 613 | 2013-03-22 | 2026-11-02 |
| Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus T900607-sodium intravenous - Gastric Cancer, Esophageal Neoplasms | Phase 2 | Suspended | Tularik | 70 | 2002-09-01 | 2005-06-24 |
Esophageal Neoplasms (3) · Nasopharyngeal Carcinoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Adenocarcinoma Of Esophagus (1) · Carotid Stenosis (1) · Esophageal Squamous Cell Carcinoma (1) · Lung Neoplasms (1) · Nasopharyngeal Neoplasms (1) · Neoplasms (1) · Neoplasms, Squamous Cell (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1) · Thymoma (1) · Thyroid Neoplasms (1) · Tongue Neoplasms (1)
Neoplasms by Site (10) · Neoplasms (9) · Neoplasms by Histologic Type (7) · Neoplasms, Glandular and Epithelial (6) · Carcinoma (5) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Esophageal Diseases (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Stomatognathic Diseases (4) · Nasopharyngeal Diseases (3) · Otorhinolaryngologic Diseases (3) · Otorhinolaryngologic Neoplasms (3)
Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · (225)Ac-DOTA-c(RGDyK) (1) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Albumin-Bound Paclitaxel (1) · Atorvastatin (1) · Biological Products (1) · Biopsy (1) · CTLA-4 Antigen (1) · Cetuximab (1) · Cisplatin (1) · Docetaxel (1) · Everolimus (1) · Injections (1) · Ipilimumab (1)
National Cancer Institute (NCI) (2) · Cancer Research UK (1) · National Cancer Centre, Singapore (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Sunnybrook Health Sciences Centre (1) · Thomas Jefferson University (1) · Tularik (1) · University of Wisconsin, Madison (1) · Zhejiang Cancer Hospital (1)
United States (5) · Canada (2) · China (2) · Hong Kong (1) · Singapore (1) · United Kingdom (1)
Ari J Rosenberg (1) · Carri Glide-Hurst, PhD, DABR, FAAPM (1) · Chen Ming, MD (1) · Daniel Tan, BSc, MBBS, PhD (1) · Fiona Blackhall, Prof (1) · Ian Poon, MD, FRCPC (1) · Kerrie Boyd (1) · Marcia Brose, MD, PhD (1) · Paul M Harari (1) · Ying Peng, Ph.D (1) · Yujin Xu, MD (1)
2019 (1), R01HL153720 (1), U10CA021661 (1), U10CA180821 (1), U10CA180868 (1)